KAITLYN SPRADLING: Open Payments
NPI 1750827077 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 6 payments from 5 companies in 2025. Trend: 2023 $35 · 2024 $150 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $247 |
| Amgen Inc. | 1 | $143 |
| Abbott Laboratories | 1 | $117 |
| Lilly USA, LLC | 1 | $105 |
| MERZ NORTH AMERICA, INC. | 1 | $46 |
Products named: REPATHA, Ozempic, Wegovy, FREESTYLE LIBRE 3, KISUNLA, Xeomin.
Industry payments across AZ — which companies pay providers there.
